Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery

Sponsor
Ankara University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05598294
Collaborator
(none)
190
1
2
13
14.6

Study Details

Study Description

Brief Summary

The clinical progress of the patients whose mobilization the investigators follow up with wearable technology products will be observed in the early postoperative period until discharge. In this way, the investigators primarily aim to examine whether the bowel movements of our more mobilized patients return earlier.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mobilization recommendations
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
190 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Screening
Official Title:
Can Wearable Technology Products Change Our Patient Management in Laparoscopic Colorectal Cancer Surgery
Anticipated Study Start Date :
Nov 15, 2022
Anticipated Primary Completion Date :
Nov 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

Standard treatment and mobilization recommendations will be given to this group.

Experimental: Mobilization Group

Mobilization of patients will be encouraged.

Procedure: Mobilization recommendations
Standard mobilization recommendations will be given to all patients, and feedback will be given to the intervention group to increase the number of steps 4 times a day according to the daily targeted number of steps.

Outcome Measures

Primary Outcome Measures

  1. Time to start flatus [1 year]

Secondary Outcome Measures

  1. Rate of Complications [1 year]

  2. Length of stay [1 year]

  3. Rate of Mortality [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who underwent laparoscopic abdominal surgery

  • Colorectal cancer patients

  • Curative surgeries

  • Stage 0,1,2,3 patients

Exclusion Criteria:
  • Patients who cannot walk

  • Patients converted to open procedure

  • Patients with ostomy

  • Patients for whom laparoscopy is contraindicated

  • Palliative surgeries

  • Patients with distant organ metastases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara University Faculty of Medicine, Surgical Oncology Department Ankara Turkey 06620

Sponsors and Collaborators

  • Ankara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kamil Erozkan, Clinical Fellow, Ankara University
ClinicalTrials.gov Identifier:
NCT05598294
Other Study ID Numbers:
  • AnkaraUSurgOnc
First Posted:
Oct 28, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2022